Sergei Doulatov, PhD is an Associate Professor with the Division of Hematology and an Adjunct Associate Professor with the Division of Genome Sciences in the Department of Medicine at the University of Washington. The Doulatov lab seeks to understand how genetic alterations in normal hematopoietic stem cells (HSCs) drive the development of myeloid neoplasms, including myelodysplastic syndromes (MDS) and acute leukemias.
Recently Dr. Doulatov and his lab has published not just 1, but 3 new papers with groundbreaking discoveries in stem cell research. Here at the University we recognize his contributions to the field and look forward to the bright future he brings to stem cell research. To learn more about his recent papers see the following links:
Reilly et al.
Cell Stem Cell: Lamin B1 deletion in myeloid neoplasms causes nuclear anomaly and altered hematopoietic stem cell function
UW Medicine Newsroom: Gene deletion behind anomaly in blood cancer cells
ISCRM News: Deletion of Lamin B1 Linked to Nuclear Abnormalities Seen in Cancer
Science in Seattle: Lamin B1 Deletion in Myeloid Neoplasms Causes Nuclear Anomaly and Altered Hematopoietic Stem Cell Function
Clough et al.
Blood, cover of March 31 issue: Coordinated missplicing of TMEM14C and ABCB7 causes ring sideroblast formation in SF3B1-mutant myelodysplastic syndrome
Stolla et al.
Blood Advances: ATG4A regulates human erythroid maturation and mitochondrial clearance